After clinical trial rejection and no word on technology transfer, Olix rides a rollercoaster amid Peptron shock
Predicted impact: Low
Clinical trial rejection and unannounced technology transfer; vague, no size given, small relative to news flow.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.